APA Alıntı

Heikkinen, T., Valkonen, H., Lehtonen, L., Vainionpaa, R., & Ruuskanen, O. (2005). Hospital admission of high risk infants for respiratory syncytial virus infection: Implications for palivizumab prophylaxis. BMJ Group.

Chicago Stili Alıntı

Heikkinen, T., H. Valkonen, L. Lehtonen, R. Vainionpaa, ve O. Ruuskanen. Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis. BMJ Group, 2005.

MLA Alıntı

Heikkinen, T., et al. Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis. BMJ Group, 2005.